Oncocyte $OCX CFO Andrea S. James sheds light on her personal career path and her past experiences with companies such as Tesla $TSLA, that led to her senior role with the molecular diagnostics technology company. morningstar.com/news/globe-new…

.OS Therapies NYSE American: OSTX Appoints Borys Shor, PhD to ADC Advisory Board bit.ly/3yEODbj #OSTherapies #investors

.Lipella (NASDAQ: $LIPO) Launches Innovative Registry to Advance Oral Lichen Planus Research bit.ly/4fWHXGk #investors #LipellaPharma #OLP

$AMS: American Shared Hospital Services Benefits of Rhode Island, New International JV, Expected ‘Asset-Light’ Model buff.ly/3MhF7Ol

.Lipella $LIPO to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York #stockstowatch #stocksinnews #investors #smallcaps pcgadvisory.com/pcgnews/lipell…

.OS Therapies NYSE American: OSTX $OSTX Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose #stockstowatch #stocksinnews #investors #smallcaps pcgadvisory.com/pcgnews/os-the…

.BioStem Technologies (OTCQB: BSEM) $BSEM To Present At The H.C. Wainwright 26th Annual Global Investment Conference In New York On September 9th At 3:30 PM ET #investors #daytrader #stockstowatch #smallcaps pcgadvisory.com/pcgnews/bioste…

scr.zacks.com/news/news-deta…

.Aclarion $ACON Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market #stockstowatch #stocksinnews #investors #daytrader pcgadvisory.com/pcgnews/aclari…

OS Therapies NYSE American: OSTX $OSTX will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference in NYC, September 9-11, 2024. Join CEO Paul Romness, as he highlights the fully-enrolled Phase 2b trial of OST-HER2 for osteosarcoma, the pivotal safety study for canine

Aclarion $ACON Added to PRISM Emerging Medical Devices Index finance.yahoo.com/news/aclarion-… #ACON #StocksToWatch

.Quoin Pharmaceuticals $QNRX Announces Insider Share Purchases by Co-Founders CEO and COO #stockstowatch #stocksinnews #investors #smallcaps pcgadvisory.com/pcgnews/quoin-…

.Aclarion $ACON Announces Completion of First Nociscan Exams in LIFEHAB Trail #stockstowatch #stocksinnews #investors #smallcaps bit.ly/3ZiifG8

Quoin Pharmaceuticals Announces Insider Share Purchases by CEO and COO, Highlighting Confidence in Company’s Growth $QNRX prismmarketview.com/quoin-pharmace…

.Aclarion (Nasdaq: $ACON) announced key milestones for its Nociscan AI platform, including peer-reviewed publications, new commercial agreements, and payer coverage decisions. With over $50M invested, 40+ patents secured, and three of the four largest UK insurers now

.OS Therapies NYSE American: OSTX $OSTX Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates #investors #stocksinnews #Daytrader #smallcaps pcgadvisory.com/pcgnews/os-the…

ANEW MEDICAL $WENA, Inc. Announces Name Change to Klotho Neurosciences $KLTO, Inc. #stockstowatch #stocksinnews #investors #daytrader #smallcaps pcgadvisory.com/pcgnews/anew-m…